Wilson Troy Edward
- SEC CIK
- 0001589597
In the past year, 2 open-market purchase filings worth $2.35M and 2 sale filings worth $123.3K.
Current role at each company
- PBYI Puma Biotechnology, Inc.Directoras of Sep 16, 2026
- KURA Kura Oncology, Inc.President and CEOas of Aug 24, 2026
- RNA Atrium Therapeutics, Inc.Directoras of Mar 2, 2026
- Avidity Biosciences, Inc.Directoras of Feb 27, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $2.35M
- 2 filings
- Sold
- $123.3K
- 2 filings
- Net
- +$2.23M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Wilson Troy Edward as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PBYI Puma Biotechnology, Inc.
Director6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 21, 2022 (view filing) | Jun 16 | 5 days | Wilson Troy EdwardDirector | SSale | −27.9K | $2.58 | −$71.9K | −50.5%27.4K after | |
| Jun 15, 2023 (view filing) | Jun 13 | 2 days | Wilson Troy EdwardDirector | SSale | −27.0K | $3.45 | −$93.2K | −98.7%350 after | 10b5-1 |
| Jun 17, 2024 (view filing) | Jun 13 | 4 days | Wilson Troy EdwardDirector | SSale | −27.0K | $3.33 | −$89.9K | −98.7%350 after | 10b5-1 |
| Jun 17, 2025 (view filing) | Jun 13 | 4 days | Wilson Troy EdwardDirector | SSale | −10.8K | $3.40 | −$36.7K | −19.9%43.5K after | 10b5-1 |
| Jun 15, 2026 (view filing) | Jun 12 | 3 days | Wilson Troy EdwardDirector | SSale | −10.8K | $7.20 | −$77.8K | −15.3%59.8K after | 10b5-1 |
| Sep 16, 2026 (view filing)9:13 PM ET | Sep 14 | 2 days | Wilson Troy EdwardDirector | SSale | −5.00K | $9.10 | −$45.5K | −8.4%54.8K after | 10b5-1 |
KURA Kura Oncology, Inc.
President and CEO6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 26, 2024 (view filing) | Jan 24 | 2 days | Wilson Troy EdwardPresident and CEO | SSale | −91.1K | $20.23 | −$1.84M | −99.4%559 after | 2 lots |
| Aug 14, 2025 (view filing) | Aug 12-13 | 2 days | Wilson Troy EdwardPresident and CEO | PPurchase | +50.0K | $6.06 | +$303.2K | +5,165.3%51.0K after | 2 lots |
| Sep 9, 2025 (view filing) | Sep 8 | 1 day | Wilson Troy EdwardPresident & CEO | PPurchase | +50.0K | $8.20 | +$410.0K | +98.1%101.0K after | |
| Sep 29, 2025 (view filing) | Sep 29 | Same day | Wilson Troy EdwardPresident and CEO | SSale | −36.6K | $8.94 | −$327.3K | −12.9%246.9K after | |
| Aug 17, 2026 (view filing)4:45 PM ET | Aug 17 | Same day | Wilson Troy EdwardPresident and CEO | PPurchase | +100.0K | $11.12 | +$1.11M | +35.8%379.2K after | |
| Aug 24, 2026 (view filing)5:30 PM ET | Aug 24 | Same day | Wilson Troy EdwardPresident and CEO | PPurchase | +100.0K | $12.39 | +$1.24M | +26.4%479.2K after |
Avidity Biosciences, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 8, 2025 (view filing) | Aug 6 | 2 days | Wilson Troy EdwardDirector | SSale | −29.5K | $45.00 | −$1.33M | −29.8%69.4K after | 2 lots10b5-1 |
| Aug 8, 2025 (view filing) | Aug 6 | 2 days | Wilson Troy EdwardDirector | SSale | −65.6K | $45.00 | −$2.95M | −78.7%17.8K after | 4 lots10b5-1 |
| Sep 9, 2025 (view filing) | Sep 5 | 4 days | Wilson Troy EdwardDirector | SSale | −29.5K | $50.00 | −$1.48M | −35.2%54.4K after | 2 lots10b5-1 |